A detailed history of Credit Agricole S A transactions in Exact Sciences Corp stock. As of the latest transaction made, Credit Agricole S A holds 15,691 shares of EXAS stock, worth $1.03 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,691
Previous 22,152 29.17%
Holding current value
$1.03 Million
Previous $1.53 Million 56.7%
% of portfolio
0.0%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$41.33 - $74.26 $267,033 - $479,793
-6,461 Reduced 29.17%
15,691 $662,000
Q1 2024

May 14, 2024

BUY
$56.27 - $73.77 $243,142 - $318,760
4,321 Added 24.23%
22,152 $1.53 Million
Q4 2023

Feb 13, 2024

BUY
$59.06 - $75.72 $105,244 - $134,933
1,782 Added 11.1%
17,831 $1.32 Million
Q3 2023

Nov 14, 2023

BUY
$65.94 - $99.04 $544,598 - $817,971
8,259 Added 106.02%
16,049 $1.09 Million
Q2 2023

Jul 31, 2023

BUY
$62.68 - $95.05 $315,907 - $479,052
5,040 Added 183.27%
7,790 $731,000
Q4 2022

Feb 13, 2023

BUY
$30.35 - $53.15 $83,462 - $146,162
2,750 New
2,750 $136,000
Q2 2022

Aug 08, 2022

SELL
$35.61 - $76.23 $1.14 Million - $2.43 Million
-31,910 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$116.57 - $155.01 $104,913 - $139,509
900 Added 2.9%
31,910 $4.21 Million
Q4 2020

Feb 12, 2021

BUY
$99.61 - $142.12 $1.18 Million - $1.68 Million
11,855 Added 61.89%
31,010 $4.11 Million
Q3 2020

Nov 13, 2020

BUY
$72.92 - $102.01 $1.4 Million - $1.95 Million
19,155 New
19,155 $1.95 Million
Q1 2018

May 14, 2018

SELL
$39.82 - $57.53 $796,400 - $1.15 Million
-20,000 Closed
0 $0
Q4 2017

Feb 13, 2018

SELL
$46.49 - $60.51 $2.43 Million - $3.16 Million
-52,300 Reduced 72.34%
20,000 $1.05 Million
Q3 2017

Nov 14, 2017

BUY
$37.05 - $47.12 $577,980 - $735,072
15,600 Added 27.51%
72,300 $3.41 Million
Q2 2017

Aug 14, 2017

BUY
N/A
56,700
56,700 $2.01 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $11.7B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Credit Agricole S A Portfolio

Follow Credit Agricole S A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Agricole S A, based on Form 13F filings with the SEC.

News

Stay updated on Credit Agricole S A with notifications on news.